The Vita Coco Company Inc vs Pfizer Inc — how do they compare? The Vita Coco Company Inc trades at $74.45 (market cap $4.26B), while Pfizer Inc trades at $24.3 (market cap $139.52B). The key difference: Pfizer Inc is far larger — about 32.8× The Vita Coco Company Inc's market cap, and Pfizer Inc pays a 7.03% dividend while The Vita Coco Company Inc pays none. Which is the better fit depends on your goals.
| COCO | PFE | |
|---|---|---|
Market Cap | $4.26B | $139.52B |
Sector | Technology | Health |
52-Week High | $84.02 | $28.56 |
52-Week Low | $32.30 | $23.29 |
Enterprise Value | $4.07B | $190.18B |
Volume | — | 29,869,932 |
Dividend Yield | — | 7.03% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $24.25, up 0.33% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 EPS of $0.75, beating expectations, and maintains a dividend of $0.43 per share. Recent news highlights Pfizer's focus on its obesity and oncology pipeline, with key catalysts expected in 2026. Financials show revenue of $62.58B in 2025, with a net income margin of 11.83% and a P/E ratio of 18.69.
The outlook for Pfizer is mixed, with analyst consensus leaning toward Hold (58.98%) but a price target of $28.78 suggesting potential upside. Investment opportunities include a strong dividend yield and pipeline advancements, while risks involve patent cliffs and competitive pressures. The stock's current valuation appears reasonable, but execution on pipeline developments is critical for future growth.
Trailing returns across standard periods
Latest headlines on both assets
The Vita Coco Company is a leading functional beverage brand specializing in coconut water. Its portfolio includes its flagship Vita Coco brand, clean energy drinks, and sustainable enhanced water products.
Read more on COCO →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →